Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis

被引:124
作者
Mills, Edward J. [1 ,2 ]
Wu, Ping [2 ]
Lockhart, Ian [3 ]
Thorlund, Kristian [1 ]
Puhan, Milo [4 ]
Ebbert, Jon O. [5 ]
机构
[1] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada
[2] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada
[3] Pfizer Ltd, Surrey, England
[4] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[5] Mayo Clin, Rochester, MN USA
基金
加拿大健康研究院;
关键词
Bupropion; Multiple treatment comparison; Meta-analysis; Nicotine replacement therapy; Systematic review; Varenicline; RECEPTOR PARTIAL AGONIST; SUSTAINED-RELEASE BUPROPION; PLACEBO; PHARMACOTHERAPIES; MORTALITY; EFFICACY;
D O I
10.3109/07853890.2012.705016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. This review compared the effect of high-dose nicotine replacement therapy (NRT) and combinations of NRT for increasing smoking abstinence rates compared to standard-dose NRT patch, varenicline, and bupropion on smoking abstinence. Methods. Ten electronic databases were searched (up to January 2012) for randomized controlled trials (RCT) of standard-dose (<= 22 mg) or high-dose nicotine patch therapy (> 22 mg), combination NRT (e. g. nicotine patch + nicotine inhaler), bupropion, and varenicline. Analysis consisted of random-effects pairwise meta-analysis and a Bayesian multiple treatment comparison (MTC). Results. We identified 146 RCTs (65 standard-doses of the nicotine patch (<= 22 mg); 6 high-dose NRT patch (> 22 mg); 5 high versus standard-dose NRT patch; 5 combination NRT versus inert controls; 6 combination versus single NRT patch; 48 bupropion; and 11 varenicline). The MTC found that all therapies offered treatment benefits at most time points over controls. Combination NRT and higher-dose NRT did not demonstrate consistent effects over other interventions. With the exception of varenicline, the benefits of treatments over standard-dose NRT were not retained in the long term. Conclusions. All pharmacologic treatments were significantly more effective than inert controls. Varenicline was the only treatment demonstrating effects over other options. These results should be considered in the development of clinical practice guidelines.
引用
收藏
页码:588 / 597
页数:10
相关论文
共 26 条
[1]   Chronic diseases 3 - Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use [J].
Asaria, Perviz ;
Chisholm, Dan ;
Mathers, Colin ;
Ezzati, Majid ;
Beaglehole, Robert .
LANCET, 2007, 370 (9604) :2044-2053
[2]   The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials [J].
Bucher, HC ;
Guyatt, GH ;
Griffith, LE ;
Walter, SD .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (06) :683-691
[3]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[4]   MORTALITY IN RELATION TO SMOKING - 40 YEARS OBSERVATIONS ON MALE BRITISH DOCTORS [J].
DOLL, R ;
PETO, R ;
WHEATLEY, K ;
GRAY, R ;
SUTHERLAND, I .
BRITISH MEDICAL JOURNAL, 1994, 309 (6959) :901-911
[5]   Combination Pharmacotherapy for Stopping Smoking What Advantages Does it Offer? [J].
Ebbert, Jon O. ;
Hays, J. Taylor ;
Hurt, Richard D. .
DRUGS, 2010, 70 (06) :643-650
[6]   Combination treatment with varenicline and nicotine replacement therapy [J].
Ebbert, Jon O. ;
Burke, Michael V. ;
Hays, J. Taylor ;
Hurt, Richard D. .
NICOTINE & TOBACCO RESEARCH, 2009, 11 (05) :572-576
[7]   Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials [J].
Eisenberg, Mark J. ;
Filion, Kristian B. ;
Yavin, Daniel ;
Belisle, Patrick ;
Mottillo, Salvatore ;
Joseph, Lawrence ;
Gervais, Andre ;
O'Loughlin, Jennifer ;
Paradis, Gilles ;
Rinfret, Stephane ;
Pilote, Louise .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 179 (02) :135-144
[8]   A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update - A US Public Health Service report [J].
Fiore, Michael C. ;
Jaen, Carlos Roberto ;
Baker, Timothy B. ;
Bailey, William C. ;
Bennett, Glenn ;
Benowitz, Neal L. ;
Christiansen, Bruce A. ;
Connell, Michael ;
Curry, Susan J. ;
Dorfman, Sally Faith ;
Fraser, David ;
Froelicher, Erika S. ;
Goldstein, Michael G. ;
Hasselblad, Victor ;
Healton, Cheryl G. ;
Heishman, Stephen ;
Henderson, Patricia Nez ;
Heyman, Richard B. ;
Husten, Corinne ;
Koh, Howard K. ;
Kottke, Thomas E. ;
Lando, Harry A. ;
Leitzke, Cathlyn ;
Mecklenburg, Robert E. ;
Mermelstein, Robin J. ;
Morgan, Glen ;
Mullen, Patricia Dolan ;
Murray, Ernestine W. ;
Orleans, C. Tracy ;
Piper, Megan E. ;
Robinson, Lawrence ;
Stitzer, Maxine L. ;
Theobald, Wendy ;
Tommasello, Anthony C. ;
Villejo, Louise ;
Wewers, Mary Ellen ;
Williams, Christine .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2008, 35 (02) :158-176
[9]   Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial [J].
Gonzales, David ;
Rennard, Stephen I. ;
Nides, Mitchell ;
Oncken, Cheryl ;
Azoulay, Salomon ;
Billing, Clare B. ;
Watsky, Eric J. ;
Gong, Jason ;
Williams, Kathryn E. ;
Reeves, Karen R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01) :47-55
[10]   Varenicline for Tobacco Dependence [J].
Hays, J. Taylor ;
Ebbert, Jon O. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (19) :2018-2024